Yuxin Du, M.D., from the Fudan University Shanghai Cancer Center, and colleagues updated the optimal thresholds of basal serum calcitonin levels for predicting the extent of LNM in a retrospective ...
Postoperative radioiodine (RAI) versus no radiodine therapy for patients with low-risk differentiated thyroid cancer: A systematic review and meta-analysis. Survival outcomes in radioactive ...
Origin in C cells renders disease calcitonin/CEA-secreting and non–iodine-avid, eliminating therapeutic utility of radioactive iodine and emphasizing early, definitive management. Clinical phenotypes ...
UICR does not predict radioactive iodine ablation success or disease recurrence in differentiated thyroid cancer.